Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 17, 2025
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
GlobeNewswire
·
April 17, 2025
CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, …
Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
GlobeNewswire
·
April 17, 2025
WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report …
Beghou Consulting Names Award-Winning Artificial Intelligence Executive, Thought Leader, and Inventor as New VP, AI Innovation
GlobeNewswire
·
April 17, 2025
EVANSTON, Ill., April 17, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions to life sciences companies, today announced that acclaimed artificial intelligence (AI) and machine learning leader …
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
GlobeNewswire
·
April 17, 2025
MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, April 30, 2025. OPKO’s senior …
Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
GlobeNewswire
·
April 17, 2025
CARLSBAD, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of Chris M. Storgard, M.D …
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans
GlobeNewswire
·
April 17, 2025
LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type …
Tilray Medical Introduces Cannabis Edibles in Australia
GlobeNewswire
·
April 17, 2025
SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners …
Hydreight Technologies to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
GlobeNewswire
·
April 17, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 17, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., today …
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced expanded acceptance of insurance to Medicare beneficiaries for qualifying care. Initially available to more than …
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
GlobeNewswire
·
April 17, 2025
-- Retrospective analysis reveals no significant differences in comorbidities in narcolepsy patients treated vs. not treated with sodium oxybate -- -- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most …
InnovAge Champions PACE at State Capitols to Protect Critical Care for Seniors
GlobeNewswire
·
April 17, 2025
DENVER, April 17, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the nation’s largest provider of the Program of All-inclusive Care for the Elderly (PACE) based on participants served, has engaged staff, nationwide, to …
Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors
GlobeNewswire
·
April 17, 2025
SAN DIEGO, April 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug Administration (FDA) …
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
GlobeNewswire
·
April 17, 2025
--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: …
Contrave Weight Loss: Top OTC Contrave Weight Loss Medication Alternative From PhenQ
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- If you're facing challenges with your weight, you're in good company. As per the Centers for Disease Control and Prevention (CDC), a substantial 73.6% of adults aged 20 years and above are grappling with …
Olon erhält CMO Excellence in Green Chemistry Award 2025
GlobeNewswire
·
April 17, 2025
RODANO, Italien, April 17, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. freut sich, die Verleihung des renommierten CMO Excellence in Green Chemistry Award 2025 bekanntzugeben. Diese Auszeichnung, die vom ACS Green Chemistry Institute Pharmaceutical Roundtable ( …
Olon se voit décerné le Prix d’excellence CMO en chimie verte en 2025
GlobeNewswire
·
April 17, 2025
RODANO, Italie, 17 avr. 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. a l’honneur d’annoncer qu’elle a reçu le prestigieux Prix d’excellence CMO en chimie verte (CMO Excellence in Green Chemistry Award) en 2025. Décernée par l’ACS Green Chemistry Institute …
Victoza Weight Loss: Buy OTC Victoza For Weight Loss Medication Alternative From PhenQ – Real Reviews
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- In thе last 30 yеars and thе Amеricas havе witnеssеd a significant surgе in adults diagnosеd with diabеtеs and attributеd to еscalatin ratеs of obеsity and poor diеtary habits and and sеdеntary …
Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
GlobeNewswire
·
April 17, 2025
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- What is Berberine? Berberine is an alkaloid found in plants, such as barberry. Traditional Asian medicines have long recognized the health advantages of this alkaloid. Berberine has gained popularity as …
Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism
GlobeNewswire
·
April 17, 2025
CELEBRATION, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announces the publication of “ …